300725 PharmaBlock Sciences
- 24.95
- -0.15-0.60%
PharmaBlock Sciences News
Yakishi Technology: An indicative announcement that Yakushi\'s debt conversion may trigger a downward revision of the share conversion price conditions
Pharmaceutical Stone Technology: Huatai United Securities Co., Ltd.\'s 2024 semi-annual follow-up report on Nanjing Yakshi Technology Co., Ltd.
Yakushi Technology: Announcement on Controlling Shareholders and Actual Controllers Increasing the Company\'s Shares
PharmaBlock Sciences: Investor Relations Management Information for Pharma Block Sciences on August 19, 2024 (2)
PharmaBlock Sciences: Investor Relations Management Information for Pharma Block Sciences on August 19, 2024 (1).
Pharma Block Sciences: Summary of Half-Year Report in 2024.
Pharma Block Sciences: Pharma block sciences' summary table of non-operational fund usage and other related fund transactions for the first half of 2024.
Pharma Block Sciences: pharma block sciences public opinion management system
Pharma Block Sciences: Announcement of the Supervisory Board's resolution.
Pharma Block Sciences: Half-year report for the year 2024.
Pharma Block Sciences: Special report on the use of funds raised in the first half of 2024_clean.
Pharma Block Sciences: Announcement on Increasing the Implementation Sites and Extension of Certain Investment Projects using Raised Funds_clean
Pharma Block Sciences: Verification opinion by Haitong United Securities Co., Ltd. regarding the addition of implementation locations and extension of part of the funding investment projects of Nanjing Pharma Block Sciences Co., Ltd.
Pharma Block Sciences: Announcement on the provision for asset impairment in the first half of 2024.
Pharma Block Sciences: Board of directors resolution announcement.
Pharma Block Sciences: Announcement on Share Pledges and Pledge Releases by Major Shareholders and Controlling Shareholders.
Pharma Block Sciences: Announcement on adjusting the grant price of 2022 restricted stock incentive plan.
Pharma Block Sciences: Announcement regarding the debt-for-equity swaps in the second quarter of 2024 for convertible bonds.
Pharma Block Sciences: Announcement on the Appointment of Executive Vice President of the Company.
Pharma Block Sciences: Announcement of the resolution of the 19th meeting of the third supervisory board.
Analysis
Price Target
No Data
No Data